Search Results - Tali Steinmetz
- Showing 1 - 8 results of 8
-
1
-
2
-
3
-
4
-
5
The impact of metformin on kidney disease progression and mortality in diabetic patients using SGLT2 inhibitors: a real-world cohort study by Timna Agur, Tali Steinmetz, Shira Goldman, Boris Zingerman, Dana Bielopolski, Eviatar Nesher, Ittai Fattal, Eshcar Meisel, Benaya Rozen‐Zvi
Published 2025Artigo -
6
The beneficial effects of sodium-glucose cotransporter 2 inhibitors on anemia in type 2 diabetes-a real world study by Tali Steinmetz, Shira Goldman, Kim Ben Tikva Kagan, Dana Bielopolski, Shira Buchrits, Amir Schechter, Shiri Kushnir, Adi Turjeman, Timna Agur, Alon Grossman, Anat Gafter Gvili, Benaya Rozen Zvi
Published 2025Artigo -
7
Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients—A Prospective Study by Dafna Yahav, Ruth Rahamimov, Tiki Mashraki, Naomi Ben-Dor, Tali Steinmetz, Timna Agur, Boris Zingerman, Michal Herman‐Edelstein, Shelly Lichtenberg, Haim Ben‐Zvi, Erez Bar‐Haim, Hagai Cohen, Shahar Rotem, Uri Elia, Ili Margalit, Benaya Rozen Zvi
Published 2022Artigo -
8
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial by Dafna Yahav, Erica Franceschini, Fidi Koppel, Adi Turjeman, Tanya Babich, Roni Bitterman, Ami Neuberger, Nesrin Ghanem‐Zoubi, Antonella Santoro, Noa Eliakim‐Raz, Barak Pertzov, Tali Steinmetz, Anat Stern, Yaakov Dickstein, Elias Maroun, Hiba Zayyad, Jihad Bishara, Danny Alon, Yonatan Edel, Elad Goldberg, Claudia Venturelli, Cristina Mussini, Leonard Leibovici, Mical Paul
Published 2018Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Confidence interval
Diabetes mellitus
Endocrinology
Biology
Gastroenterology
Anemia
Disease
Randomized controlled trial
Retrospective cohort study
Type 2 diabetes
Adverse effect
Agonist
Angiology
Antibiotics
Antibody
Bacteremia
Bacteria
Biochemistry
Bioinformatics
Chemistry
Clinical endpoint
Cohort
Cohort study
Cotransporter
Genetics
Glucagon-like peptide 1 receptor
Glucagon-like peptide-1
Hazard ratio